SCHEMBL1148151

SCHEMBL1148151

COc1cnc2cccc(C(O)C(O)[C@H]3CC[C@H](C(=O)Nc4ccc5c(c4)OCCO5)CC3)c2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
KCNH2 Q12809 1/20 0.43
ALDH1A1 P00352 4/20 0.42
MAPT P10636 3/20 0.42
POLB P06746 2/20 0.42
CYP2C19 P33261 2/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GAA P10253 1/20 0.41
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1147993 1.00 KDM4E (0.45) KDM4EL3MBTL1SMN1; SMN2KCNH2ALDH1A1
SCHEMBL3252259 0.88 MAPT (0.41) KDM4ESMN1; SMN2ALDH1A1MAPTPOLB
SCHEMBL1148050 0.88 KCNH2 (0.52) KDM4EL3MBTL1SMN1; SMN2KCNH2ALDH1A1
SCHEMBL1147755 0.80 TRPV1 (0.45) KDM4EALDH1A1MAPTMEN1HTT
SCHEMBL3245683 0.79 PDE4B (0.36) KDM4EKMT2AGAA
SCHEMBL3243332 0.79 PDE4B (0.36) KDM4EKMT2AGAA
SCHEMBL3243324 0.79 PDE4B (0.36) KDM4EKMT2AGAA
SCHEMBL3245687 0.79 PDE4B (0.36) KDM4EKMT2AGAA
SCHEMBL1147467 0.77 KDM4E (0.42) KDM4EL3MBTL1SMN1; SMN2KCNH2ALDH1A1
SCHEMBL3255856 0.77 KCNH2 (0.47) SMN1; SMN2KCNH2ALDH1A1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7888359-B2 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives ACTELION PHARMACEUTICAL LTD. (CH) 2011-02-15 US disclosed